login
login

Europe Daily Bulletin No. 10925

20 September 2013
Contents Publication in full By article 10 / 30
SECTORAL POLICIES / (ae) health
CTRS intends to pursue Commission over Orphacol

Brussels, 19/09/2013 (Agence Europe) - The European Commission has finally accepted the decision of the General Court of the EU and has granted CTRS marketing authorisation for the medicine known as Orphacol. The intended use of this orphan medicine is for treating two extremely rare and potentially fatal liver diseases. In a press release on 18 September, the French laboratory CTRS welcomed this decision but said, nevertheless, that it intended to take action against the Commission for...

Contents

ECONOMY - FINANCE
SECTORAL POLICIES
EXTERNAL ACTION
COURT OF JUSTICE OF THE EU
SOCIAL AFFAIRS